Brought to you by 
Siemens to create companion diagnostic for Pfizer
19 Dec 2013
Executive Summary
Siemen AG’s Siemens Healthcare Diagnostics Inc., through its Siemens Clinical Laboratory, will develop companion diagnostics (CDs) for use in the clinical development of Pfizer Inc.’s compounds in undisclosed therapy areas.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Siemens to create companion diagnostic for Pfizer
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice